Rain Therapeutics Q3 EPS $(0.70) Up From $(3.05) YoY

Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.70) per share. This is a 77.05 percent increase over losses of $(3.05) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2021

1 minute read

Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.70) per share. This is a 77.05 percent increase over losses of $(3.05) per share from the same period last year.

President And CFO Of Sun Country Airlines Trades $1.11 Million In Company Stock

By Benzinga Insights

Today, 9:46 AM

David Davis, President And CFO at Sun Country Airlines (NASDAQ:SNCY), made a large buy and sell of company shares on September 17, according to a new SEC filing.

SNCY

UPDATE: Novagold Resources Q4 Adj. EPS $(0.04) Misses $(0.03) Estimate

By Benzinga Newsdesk

Today, 9:46 AM

Novagold Resources (AMEX:NG) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 33.33 percent decrease over losses of $(0.03) per share from